重视PET/CT在多发性骨髓瘤中的应用

doi:10.16150/j.1671-2870.2017.05.003

摘要/Abstract

中图分类号:

R445.5

张一帆. 重视PET/CT在多发性骨髓瘤中的应用[J]. 诊断学理论与实践, 2017, 16(05): 464-467.

[1] Dimopoulos MA, Hillengass J, Usmani S, et al.Role of magnetic resonance imaging in the management of patients with multiple myeloma: a consensus statement[J]. J Clin Oncol,2015,33(6):657-664.
[2] Mihailovic J, Goldsmith SJ.Multiple myeloma: ¹⁸F-FDG-PET/CT and diagnostic imaging[J]. Semin Nucl Med,2015,45(1):16-31.
[3] Cavo M, Terpos E, Nanni C, et al.Role of ¹⁸F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group[J]. Lancet Oncol,2017,18(4):e206-e217.
[4] Regelink JC, Minnema MC, Terpos E, et al.Comparison of modern and conventional imaging techniques in establishing multiple myeloma-related bone disease: a systematic review[J]. Br J Haematol,2013,162(1):50-61.
[5] Weng WW, Dong MJ, Zhang J, et al.A systematic review of MRI, scintigraphy, FDG-PET and PET/CT for diagnosis of multiple myeloma related bone disease--which is best?[J]. Asian Pac J Cancer Prev,2014,15(22):9879-9884.
[6] van Lammeren-Venema D, Regelink JC, Riphagen II, et al. ¹⁸F-fluoro-deoxyglucose positron emission tomography in assessment of myeloma-related bone disease: a systema-tic review[J]. Cancer,2012,118(8):1971-1981.
[7] Sachpekidis C, Mai EK, Goldschmidt H, et al.(18)F-FDG dynamic PET/CT in patients with multiple myeloma: patterns of tracer uptake and correlation with bone marrow plasma cell infiltration rate[J]. Clin Nucl Med,2015,40(6):e300-e307.
[8] Salaun PY, Gastinne T, Frampas E, et al.FDG-positrone-mission tomography for staging and therapeutic assessment in patients with plasmacytoma[J]. Haematologica,2008,93(8):1269-1271.
[9] Zamagni E, Patriarca F, Nanni C, et al.Prognostic relevance of 18-F FDG PET/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation[J]. Blood,2011,118(23):5989-5995.
[10] Patriarca F, Carobolante F, Zamagni E, et al.The role of positron emission tomography with ¹⁸F-fluorodeoxyglucose integrated with computed tomography in the evaluation of patients with multiple myeloma undergoing allogeneic stem cell transplantation[J]. Biol Blood Marrow Transplant,2015,21(6):1068-1073.
[11] Bartel TB, Haessler J, Brown TL, et al.F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma[J]. Blood,2009,114(10):2068-2076.
[12] Nanni C, Zamagni E, Celli M, et al.The value of ¹⁸F-FDG PET/CT after autologous stem cell transplantation (ASCT) in patients affected by multiple myeloma (MM): experience with 77 patients[J]. Clin Nucl Med,2013,38(2):e74-e79.
[13] Usmani SZ, Mitchell A, Waheed S, et al.Prognostic implications of serial 18-fluoro-deoxyglucose emission tomography in multiple myeloma treated with total therapy 3[J]. Blood,2013,121(10):1819-1823.
[14] Fonti R, Larobina M, Del Vecchio S, et al.Metabolic tumor volume assessed by ¹⁸F-FDG PET/CT for the prediction of outcome in patients with multiple myeloma[J]. J Nucl Med,2012,53(12):1829-1835.
[15] Zamagni E, Nanni C, Gay F, et al.¹⁸F-FDG PET/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease[J]. Leukemia,2016, 30(2):417-422.
[16] Mateos MV, Hernández MT, Giraldo P, et al.Lenalidomide plus dexamethasone versus observation in patients with high-risk smouldering multiple myeloma (QuiRedex): long-term follow-up of a randomised, controlled, phase 3 trial[J]. Lancet Oncol,2016,17(8):1127-1136.
[17] Albano D, Bosio G, Treglia G, et al. ¹⁸F-FDG PET/CT in solitary plasmacytoma: metabolic behavior and progression to multiple myeloma[J/OL]. Eur J Nucl Med Mol Imaging.2017-08-19[2017-10-25]. https://www.ncbi.nlm.nih.gov/pubmed/28822997.
[18] Lapa C, Knop S, Schreder M, et al.¹¹C-Methionine-PET in Multiple Myeloma: Correlation with Clinical Parameters and Bone Marrow Involvement[J]. Theranostics,2016, 6(2):254-261.
[19] Lin C, Ho CL, Ng SH, et al.(11)C-acetate as a new biomarker for PET/CT in patients with multiple myeloma: initial staging and postinduction response assessment[J]. Eur J Nucl Med Mol Imaging,2014,41(1):41-49.
[20] Nanni C, Zamagni E, Cavo M, et al.¹¹C-choline vs. ¹⁸F-FDG PET/CT in assessing bone involvement in patients with multiple myeloma[J]. World J Surg Oncol,2007,5:68.
[21] Wester HJ, Keller U, Schottelius M, et al.Disclosing the CXCR4 expression in lymphoproliferative diseases by targeted molecular imaging[J]. Theranostics,2015,5(6):618-630.
[22] Herrmann K, Schottelius M, Lapa C, et al.First-in-human experience of CXCR4-directed endoradiotherapy with ¹⁷⁷Lu- and ⁹⁰Y-labeled pentixather in advanced-stage multiple myeloma with extensive intra- and extramedullary disease[J]. J Nucl Med,2016,57(2):248-251.

重视PET/CT在多发性骨髓瘤中的应用

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	何亲羽, 王伟, 陈立芬, 张雪蕾, 董治亚. LHCGR基因突变致家族性男性性早熟2例报告及文献复习[J]. 诊断学理论与实践, 2022, 21(05): 598-605.
[2]	陈志敏, 何浩岚. 艾滋病合并马尔尼菲篮状菌病的诊治现状[J]. 诊断学理论与实践, 2022, 21(04): 425-430.
[3]	沈银忠. 《人类免疫缺陷病毒感染/艾滋病合并结核分枝杆菌感染诊治专家共识》解读[J]. 诊断学理论与实践, 2022, 21(04): 431-436.
[4]	屈骞, 海汪溪, 胡生焰, 张敏, 陈肖玥, 周熠磊, 王瑾, 胡晓平, 李彪, 胡佳佳. 多巴胺转运蛋白显像探针¹⁸F-FP-CIT的AllinOne模块自动化制备及大鼠基底节Micro PET/CT显像[J]. 诊断学理论与实践, 2022, 21(04): 482-489.
[5]	陈宏, 沈银忠. 人类免疫缺陷病毒感染/艾滋病合并结核病的诊治进展[J]. 诊断学理论与实践, 2022, 21(04): 530-534.
[6]	何新, 陈慧, 冯炜炜. 机器学习算法在辅助超声诊断附件肿块良恶性中的应用研究进展[J]. 诊断学理论与实践, 2022, 21(04): 541-546.
[7]	徐子真, 李擎天, 刘湘帆, 李莉, 李惠, 王也飞, 吴洁敏, 陈宁, 梁璆荔, 陈松立, 戴健敏, 宋珍, 丁磊. 实验诊断学在线课程的建立和实践[J]. 诊断学理论与实践, 2022, 21(04): 547-550.
[8]	赵然, 詹维伟, 侯怡卿. 计算机辅助诊断系统辅助超声诊断甲状腺弥漫性病变合并结节良恶性的应用价值[J]. 诊断学理论与实践, 2022, 21(03): 390-394.
[9]	郭业兵, 郑金峰. 阴道壁胃肠道外间质瘤一例报道并文献复习[J]. 诊断学理论与实践, 2022, 21(03): 405-407.
[10]	王刚, 陈生弟. 神经病学的诊断：起源、发展及挑战[J]. 诊断学理论与实践, 2022, 21(01): 1-4.
[11]	唐静仪, 余群, 刘军. 结合人工智能的结构影像分析对阿尔茨海默病的早期预测及精准诊断研究进展[J]. 诊断学理论与实践, 2022, 21(01): 12-17.
[12]	魏文石. 直面我国阿尔茨海默病诊治的挑战——《中国阿尔茨海默病报告2021》解读[J]. 诊断学理论与实践, 2022, 21(01): 5-7.
[13]	王蔚, 王小钦. 缺铁性贫血的病因诊断[J]. 诊断学理论与实践, 2021, 20(06): 529-532.
[14]	岳婧婧, 宋琦, 江旭峰, 王黎, 赵维莅, 严福华. 磁共振全身扩散加权成像结合T2WI抑脂序列与FDG-PET/CT在初发淋巴瘤分期及病灶检出的对比研究[J]. 诊断学理论与实践, 2021, 20(06): 540-546.
[15]	王昭晖, 吴海波. 胃神经鞘瘤31例临床病理学分析[J]. 诊断学理论与实践, 2021, 20(06): 552-556.